MACOM Technology Solutions vs Synaptics
MTSI and SYNA side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MTSI and SYNA compare
MACOM Technology Solutions is the larger company, worth 3.8 times as much as Synaptics ($17.4B against $4.6B).
MACOM Technology Solutions grew revenue faster over the last twelve months (28.4% versus 11.4% for Synaptics).
MACOM Technology Solutions keeps more of each dollar of sales as profit, with a net margin of 20.7% compared with −41.0% at Synaptics.
MACOM Technology Solutions scores higher on the StockData Score (14 against 3 for Synaptics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MTSI | SYNA |
|---|---|---|
| Size and price | ||
| Market cap | $17.4B | $4.6B |
| Share price | $227.36 | $117.36 |
| Change, 1 year | 39.9% | 82.3% |
| Change, 5 years | 209% | −56.8% |
| Beta (5Y) | 2.69 | 2.04 |
| Employees | 2,000 | 1,700 |
| StockData Score | ||
| Total score | 14 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 3 (better) | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 72.6× | – |
| P/S | 14.9× | 3.8× (better) |
| P/B | 11.3× | 4.9× (better) |
| EV/EBITDA | 64.8× | – |
| P/FCF | 85.1× | 45.3× (better) |
| FCF yield | 1.2% | 2.2% (better) |
| Fair value | $123.09 | $93.44 |
| Margin of safety | −84.7% | −25.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 28.4% (better) | 11.4% |
| Revenue growth, 5Y average | 12.8% (better) | −2.2% |
| Profitability | ||
| Gross margin | 56.5% (better) | 44.7% |
| Operating margin | 18.1% (better) | −5.6% |
| Net margin | 20.7% (better) | −41.0% |
| FCF margin | 17.5% (better) | 8.5% |
| Return on equity | 17.2% (better) | −42.2% |
| Return on invested capital | 15.8% (better) | −3.4% |
| Financial health | ||
| Debt / equity | 0.22 (better) | 0.90 |
| Net debt / EBITDA | −1.23 | – |
| Current ratio | 2.34 (better) | 1.12 |
| Altman Z-score | 18.40 (better) | 3.33 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 2.0% |
| Shareholder yield | 0.00% | 2.0% (better) |
| Ownership | ||
| Held by institutions | 95.9% | 107% |
| Held by insiders | 6.7% | 3.1% |
| Insider net buying, 12 months | −$298M | −$8.7M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.0% | 6.4% |
Go deeper
- MTSI stock overview
- MTSI income statement
- MTSI valuation and score
- SYNA stock overview
- SYNA income statement
- SYNA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.